Full Text (PDF)
Review Article

Antiphospholipid Antibody Syndrome in Pregnancy

Pallavi Y. Untwal, Speciality Medical Officer, Dept. of OBGY, Lokmanya Tilak Municipal Medical College (LTMMC) & Lokmanya Tilak Municipal General Hospital (LTMGH), Sion, Mumbai, Maharashtra 400022, India. , Pallavi Y. Untwal1 , Alka B. Patil2

Author Information

Licence:




Indian Journal of Maternal-Fetal & Neonatal Medicine 5(1):p 86-90, January - June 2018. | DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.5118.14

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

APS in pregnancy is one of the important cause of recurrent pregnancy loss, preclampsia and IUGR. Treatment to be started after confirmation of APS with the help of laboratory and clinical criteria. With the imperfect data that are currently available it is impossible to give evidence based recommendations on how patients with APS should be treated in pregnancy. It is wise to regard pregnancies as being at high risk. Treatment to be started with prepregnancy councelling followed by follow up during pregnancy and treatment.

Keywords: APS; Antiphospholipid Antibody (aPL); Recurrent prgnancy loss; Preclampsia. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.5118.14

Keywords


Article Level Metrics

Last Updated

Wednesday 17 June 2026, 20:33:14 (IST)


553

Accesses

2
95
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share